MEDVi vs Trimi Health: Which GLP-1 Provider Is Better?
Short answer: MEDVi scores higher on our rubric, 5.7/10 against 4.2/10. Full reasoning, pricing and the cases where the other one wins are below.
MEDVi beats Trimi Health overall, scoring 5.7/10 vs 4.2/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Trimi Health is $175/mo month-to-month. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose Trimi Health for cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak trustpilot record plus no-pro-rating cancellation terms in exchange.
A side-by-side look at MEDVi and Trimi Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDViTrimi Health
#52 of 54Telehealth platform for compounded semaglutide and tirzepatide. Weekly injections in vial-and-syringe format only, no pens, no oral option. Pricing is flat across all doses, with the consult and overnight shipping included. Prescriptions route through the Arora Health medical group (Dr. Sean Arora MD, medical director) and are filled by VialsRx and GreenwichRx, the same backend that powers Telos RX. Founded May 2024 per the site's own schema markup; no legal entity suffix or street address is disclosed.
Visit Trimi Health| Feature | MEDVi | Trimi Health |
|---|---|---|
| Our Score | 5.7/10 | 4.2/10 |
| Headline Price | $179 first month, then $299/mo | $175/mo month-to-month |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want both oral and injectable compounded options in one telehealth program | Cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak Trustpilot record plus no-pro-rating cancellation terms in exchange |
| Watch out for | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication | Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds |
| Ranking | #46 | #52 |
| Get started | Visit MEDVi | Visit Trimi Health |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Trimi Health
Pros
- +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
- +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
- +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available
- +Named medical director, Dr. Sean Arora MD of the Arora Health medical group, most compounded-only platforms name no one
- +Compounding pharmacies named: VialsRx (TX license #35264, site-claimed) and GreenwichRx, most competitors do not name theirs
- +Available in all 50 states plus DC per trytrimi.com/states
- +6-month money-back weight-loss promise published (conditions apply, read them before counting on it)
Cons
- −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
- −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
- −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)
- −Vial-and-syringe format only, no autoinjector pens, no oral option, no brand-name medications
- −LegitScript certification claimed but we could not verify it against LegitScript's registry
- −Mandatory arbitration clause in the terms
- −Retatrutide and orforglipron are listed as 'Preparing', roadmap items, not available today, do not enroll expecting them
- −Shares its medical group (Arora Health) and pharmacy (VialsRx) with Telos RX, a white-label backend relationship neither brand discloses on its own site
Our Verdict
MEDVi edges out Trimi Health with a score of 5.7/10 vs 4.2/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Trimi Health is $175/mo month-to-month. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving MEDVi and Trimi Health.
- MEDVi vs TMatesfrom $158/mo
- MEDVi vs Galafrom $149/mo
- MEDVi vs Ivim Healthfrom $150/mo
- Trimi Health vs Direct Meds GLP-1from $297/mo
- Trimi Health vs Maximuspublished $79.99/mo; total not verified
- Trimi Health vs Embodyfrom $69/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: MEDVi · 5.7/10